Sponsor content
269 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STELARA ustekinumab 45 mg/ 0.5 mL solution for injection pre-filled pen (One-Press patient-controlled injector).
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Australian public assessment report (AusPar)Tecvayli (teclistamab) has been provisionally approved for the treatment of relapsed or refractory multiple myeloma in adult patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECVAYLI teclistamab 90mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECVAYLI teclistamab 10mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cellular Therapies - T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI - Janssen-Cilag Pty Ltd - Injection, intravenous infusion - Bag.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYBREVANT amivantamab 350 mg/7 mL concentrate for solution for infusion vial.
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd